Conversations in Oncology in China
Recent talks from Boehringer Ingelheim standalone meetings
Boehringer Ingelheim convened its newest edition of Conversations in Oncology in November 2016 in Shanghai, China. This meeting was the twelfth meeting in this series and the first Conversations in Oncology in China.
The meeting included both plenary talks as well as roundtable discussions that highlighted the key advancements in the molecular biology, testing and treatment of non-small cell lung cancer (NSCLC), focusing on targeted therapies, anti-angiogenesis agents, biomarkers, immunotherapy, and real-world treatment with patient case study discussions.
To view slides from the various presentation, simply click on your file of choice below.